Department of Medicine

October 21, 2021

VUMC lauded for hypertrophic cardiomyopathy care

Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.

By Matt Batcheldor
October 14, 2021

Tea drinking and high blood pressure

Habitual tea drinking is associated with a slightly higher risk of hypertension in middle-aged and older Chinese adults, which warrants confirmation by long-term intervention studies, researchers say.

By Sarah E. Glass
October 14, 2021

STAR Clinical Research Network to receive major grant renewal

Vanderbilt’s STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.

By Bill Snyder
October 7, 2021

Study seeks to improve kidney transplant outcomes among Black patients

By Bill Snyder
ekg results
October 7, 2021

Study finds genetic testing useful for young AFib patients

Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.

By Matt Batcheldor
October 7, 2021

Lindenfeld honored by Heart Failure Society of America

Vanderbilt’s JoAnn Lindenfeld, MD, has received the Pioneer Award from the Heart Failure Society of America (HFSA) for being an innovator and pioneer in the field of heart failure.

By Matt Batcheldor
September 30, 2021

Policy formalizes role and use of medical chaperones during patient encounters

Vanderbilt University Medical Center is implementing a new policy which standardizes and expands the role of a medical chaperone, an individual who serves as a witness for both a patient and their clinician during a sensitive medical examination or procedure.
By Jill Clendening
September 30, 2021

Study shows how a protein coding gene confers breast cancer susceptibility during DNA transcription

Vanderbilt-Ingram Cancer Center research is providing new insights into how genetic variants convey breast cancer susceptibility by altering the transcription factor proteins that convert DNA strands into RNA.
By Tom Wilemon
September 23, 2021

Stevenson receives HFSA Lifetime Achievement Award

Vanderbilt's Lynne Warner Stevenson, MD, has received  the Lifetime Achievement Award from the Heart Failure Society of America.
By Matt Batcheldor
September 23, 2021

Eng named co-chair of NCI clinical trials steering committee

Vanderbilt's Cathy Eng, MD, has been elected co-chair of the National Cancer Institute (NCI) Gastrointestinal Cancer Steering Committee.
By Tom Wilemon
September 21, 2021

The role of polarity in early cancer

Mutations in the protein epiregulin, an EGF receptor ligand, affect larger epithelial cell reorganization and may contribute to early cancer development, Vanderbilt researchers discovered.
By VUMC News and Communications
September 16, 2021

Structural variants in breast cancer risk genes

Vanderbilt epidemiologists conducted in-depth whole genome sequencing of breast cancer risk genes in Black women, who die at higher rates and have more aggressive disease, to discover mutations that may improve testing and treatment selection.
By Leigh MacMillan
September 16, 2021

Chung receives early investigator award from ASCPT

Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
By Bill Snyder
1 … 51 52 53 54 55 … 124